Abstract
Tissue injury in many skin diseases is a result of immunological reactions and inflammation. The prostaglandins and their associated compounds are important in the regulation of these host responses and probably influence epidermal cell function. In this chapter we describe the biochemistry and structure of the prostaglandins and the newly discovered compounds within the metabolic pathways between essential fatty acids, the primary prostaglandins, and the nonprostanoate products. The influence of prostaglandins in initiation and regulation of immune/inflammatory processes is reviewed. The possible role of these compounds in cutaneous pathophysiology is discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramowitz, J., and Chavin, W., 1973, In vitro effects of prostaglandins upon melanosome dispersion in the skin of black goldfish, Prostaglandins 4: 805–818.
Adachi, K, Yoshikawa, K., Halprin, K. M., and Levine, V., 1975, Prostaglandins and cyclic AMP in epidermis, Br. J. Dermatol. 92: 381–388.
Amache, N., and Brummer, M. C., 1968, A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts, Br. J. Pharmacol. Chemother. 33: 162–170.
Ambache, N., Kavanaugh, L., and Whiting, J., 1965, Effect of mechanical stimulation on rabbits’ eyes: Release of active substance in anterior chamber of perfusates, J. Physiol. (London) 176: 378–408.
Anggard, E., 1971, Studies on the analysis and metabolism of the prostaglandins, Ann. N.Y. Acad. Sci. 180: 200–218.
Anggard, E., and Jonsson, C. E., 1972, Formation of prostaglandins in the skin following burn injury, in: Prostaglandins in Cellular Biology ( P. W. Ramwell and B. B. Pharriss, eds., pp. 269–292, Plenum Press, New York.
Anggard, E., Bohman, S. L., Griffin, J. E., III, Larsson, C., and Maunsbach, A. B., 1972, Subcellular localization of prostaglandin system in the rabbit renal papilla. Prostaglandins in renal papilla, Acta Physiol. Scand. 84: 231–246.
Aso, K., Orenberg, E. K., and Farber, E. M., 1975, Reduced epidermal cyclic AMP accumulation following prostaglandin stimulation: Its possible role in the pathophysiology of psoriasis, J. Invest. Dermatol. 65: 375–378.
Aso, K., Rabinowitz, I., and Farber, E. M., 1976, The role of prostaglandin El cyclic AMP and cyclic GMP in the proliferation of guinea-pig ear skin stimulated by topical application of vitamin A acid, J. Invest. Dermatol. 67: 231–234.
Bach, M. A., 1975, Differences in cyclic AMP changes after stimulation by prostaglandins and isoproterenol in lymphocyte subpopulations, J. Clin. Invest. 55: 1074–1081.
Bito, L. Z., 1975, Saturable, energy dependent transmembrane transport of prostaglandins against concentration gradients, Nature (London) 256: 134–136.
Bonta, I. L., Parnham, M. J., Van Vliet, L., and Vincent, J. E., 1977, Mutual enhancement of the effects of prostaglandin El and theophylline on the Freund adjuvant-induced arthritis syndrome of rats, Br. J. Pharmacol. 59: 438–439 P.
Boume, H. R., Lichtenstein, L. M., Melmon, K. L., Henney, C. S., Weinstein, Y., and Shearer, G. M., 1974, Modulation of inflammation and immunity by cyclic AMP, Science 184: 19–28.
Braun, W., 1974, Regulatory factors in the immune response, in: Cyclic Nucleotides, Immune Responses and Tumor Growth ( W. Braun, C. W. Parker, and L. M. Lichtenstein, eds.), Academic Press, New York.
Chandrabose, K. A., Lapetina, E. G., Schmitges, C. J., Siegel, M. I., and Cuatrecasas, P., 1978, Action of corticosteriods in regulation of prostaglandin biosynthesis in cultured fibroblasts, Proc. Natl. Acad. Sci. USA 75: 214–217.
Chang, W. C., Murota, S., and Tsurufuji, S., 1977, Thromboxane B2 transformed from arachidonic acid in corrageenin induced granuloma, Prostaglandins 13: 1724.
Collier, H. O. J., 1971, Prostaglandins and aspirin, Nature (London) 232: 17–19.
Crunkhorn, P., and Willis, A. L., 1971a, Cutaneous reactions to intradermal prostagladins, Br. J. Pharmacol. 41: 49–56.
Crunkhorn, P., and Willis, A. L., 1971b, Interaction between prostaglandins E and F given intradermally in the rat, Br. J. Pharmacol. 41: 507–512.
Dale, H. H., 1927, Some chemical factors in the control of the circulation, Lancet 1: 1285–1290.
DiRosa, M., and Sorrentino, L., 1970, Some pharmacodynamic properties of corrageenan in the rat, Br. J. Pharmacol. 38: 214–220.
DiRosa, M., Giroud, J. P., and Willoughby, D. A., 1971, Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine, J. Pathol. 104: 15–29, 1971.
Eaglstein, W. H., and Weinstein, G. D., 1975, Prostaglandin and DNA synthesis in human skin: Possible relation to ultraviolet light effects, J. Invest. Dermatol. 64: 386–389.
Ferraris, V.A., DeRubertis, F. R., Hudson, T. H., and Wolfe, L., 1974, Release of prostaglandin by mitogenand antigen-stimulated leukocytes in culture, J. Clin. Invest. 54: 378–386.
Ferreira, S. H., 1972, Prostaglandins, aspirin like drugs and analgesia, Nature (London) New Biol. 240: 200–203.
Ferreira, S. H., and Vane, J.R., 1974, Aspirin and prostaglandins, in: The Prostaglandins ( P. Ramwell, ed.), pp. 1–47, Plenum Press, New York.
Ferreira, S. H., Nakamura, M., and Castro, M.S.A., 1978, The hyperalgesic effects of prostacyclin and prostaglandin E2, Prostaglandins 16: 31–37.
Flower, R., 1978, Steroidal anti-inflammatory drugs as inhibitors of phospholipase A2, Adv. Prostaglandin Thromboxane Res. 3: 105–112.
Fridovich, I., 1975, Superoxide dismutases, Annu. Rev. Biochem. 44: 147–159.
Glenn, E. M., and Rohloff, N., 1972, Antiarthritic and antiinflammatory effects of certain prostaglandins, Proc. Soc. Exp. Biol. Med. 139: 290–294.
Goldstein, A., Schied, M., Hammerling, U., Boyse, E. A., Schlesinger, D. H., and Niall, H. D., 1975, Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells, Proc. Natl. Acad. Sci. USA 72: 11–15.
Goldstein, I. M., Malmsten, C. L., Kaplan, H. B., Jindahl, H., Samuelsson, B., and Weissmann, G., 1977, Thromboxane generation by stimulated human granulocytes: Inhibition by glucocorticoids and superoxide dismutase, Clin. Res. 25: 518A.
Goldyne, M. E., 1975, Prostaglandins and cutaneous inflammation, J. Invest. Dermatol. 64: 337–385.
Goldyne, M., Winkelmann, R. K., and Ryan, R. J., 1973, Prostaglandin activity in human cutaneous inflammation: Detection by radioimmunoassay, Prostaglandins 4: 737–749.
Goodwin, J. S., Bankhurst, A. D., and Messner, R. P., 1977, Suppression of human T-cell mitogenesis by prostaglandin, J. Exp. Med. 146: 1719–1734.
Gordon, D., Bray, M.A., and Morley, J., 1976, Control of lymphokine secretion by prostaglandins, Nature(London) 262: 401–402.
Greaves, M.W., and McDonald-Gibson, W., 1973, Itch: Role of prostaglandins, Br. Med. J. 3: 608–6.
Greaves, M. W., and SOndergaard, J. S., 1970, Pharmacologic agents released in ultraviolet inflammation studied by continuous skin perfusion, J. Invest. Dermatol. 54: 365–367.
Greaves, M. W., Sylndergaard, J., and McDonald-Gibson, W., 1971, Recovery of prostaglandins in human cutaneous inflammation, Br. Med. J. 2: 258–260.
Greenberg, R. A., Eaglstein, W. H., Turnier, H., and Houd, P. V., 1975, Orally given indomethacin and blood flow response to UVL, Arch. Dermatol. 111: 328–330.
Grinwich, K. D., and Plescia, O. J., 1977, Tumor mediated immunosuppression: Prevention by inhibitors of prostaglandin synthesis, Prostaglandins 14: 1175–1182.
Gryglewski, R. J., Panczenko, B., Korbut, R., Grodzinska, L., and Ocetkiewicz, A., 1975, Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessels of rabbit and from perfused lungs of sensitized guinea pig, Prostaglandins 10: 343–355.
Ham, E. A., Cirillo, V. J., Zanetti, M., Shen, T. Y., and Kuehl, F. A., 1972, Studies on the mode of action of non-steroidal anti-inflammatory agents, in: Prostaglandins in Cellular Biology ( P.W. Ramwell, and B. B. Pharris, eds.), pp. 345–352, Plenum Press, New York.
Hamberg, M., and Samuelsson, B., 1973, Detection and isolation of an endoperoxide intermediate in prostaglandin biosynthesis, Proc. Natl. Acad. Sci. USA 70: 899–903.
Hamberg, M., Svensson, J., and Samuelsson, B., 1975, Thromboxanes: A new group of biologically active compounds derived from prostaglandin endoperoxides, Proc. Natl. Acad., Sci. USA 72: 2994–2998.
Hansson, E., and Samuelsson, B., 1965, Autoradiographic distribution studies of 3H labeled PGE in mice, prostaglandins and related factors, Biochim. Biophys. Acta 106: 379–385.
Harris, R., Ramwell, P. W., and Gilmer, P. J., 1979, Cellular mechanisms of prostaglandin action, Annu. Rev. Physiol. 41: 653–668.
Hedqvist P., 1970, Studies on the effect of prostaglandins E 1 and E2 on the sympathetic neuromuscular transmission in some animal tissues, Acta Physio. Scand. 345:1–40 (Suppl. 79 ).
Henney, C. S., Bourne, H. R., and Lichtenstein, L. M., 1972, The role of cyclic AMP in the specific cytolytic activity of lymphocytes, J. Immunol. 108: 1526–1534.
Herscowitz, H. B., and Stylos, W. A., 1975, Prostaglandin induced enhancement of the in vitro anamnestic response, Prostaglandins 10: 88–98.
Higgs, G. A., and Youlten, L. J. F., 1972, Prostaglandin production by rabbit peritoneal PMN leucocytes in vitro, Br. J. Pharmacol. 44: 330 P.
Higgs,G. A., McCall, E., and Youlten, L. J. F., 1975, A chemotactic role for prostaglandins released from PMN leucocytes during phagocytosis, Br. J. Pharmacol. 53: 539–546.
Higgs, G. A., Bunting, S., Moncada, S., and Vane, J. R., 1976, Polymorphonuclear leucocytes produce thromboxane A2-like activity during phagocytosis, Prostaglandins 12: 749–758.
Higgs, G. A., Moncada, S., and Vane, J. R., 1978, Inflammatory effects of prostacyclin (PGI1) and 6-Oxo-PGFia in the rat paw, Prostaglandins 16: 153–162.
Hopkins, J. M., Horton, E. W., and Whittaker, V. P., 1968, Prostaglandin content of particulate and supernatant fractions of rabbit brain homogenates, Nature (London) 217: 71–72.
Horton, E. W., 1983, Action of prostaglandin E1 on tissues which respond to bradykinin, Nature (London) 200: 892–893.
Ichikawa, A., Nagasaki, M., Umezu, K., Hayashi, H., and Tornita, K., 1972, Effect of cyclic AMP on edema and granuloma induced by carrageenan, Biochem. Pharmocol. 21: 2615–2626.
Ishizuka, M., Takeuchi, T., and Umezawa, H., 1974, Promotion of antibody formation by prostaglandin, Experientia 30: 1207–1209.
Jonsson, C.-E., and Anggard, E., 1972, Biosynthesis and metabolism of prostaglandin E2 in human skin, Scand. J. Clin. Lab. Invest. 29: 289–296.
Jouvenaz, G. J., Nugteren, D. J., Beerthuis, R. K., and Van Dorp, D. A., 1970, A sensitive method for the determination of prostaglandins by gas chromatography with electron capture detection, Biochim. Biophys. Acta 202: 231–234.
Kaidbey, K. H., and Kurban, A. K., 1976, The influence of corticosteroids and topical indomethacin on sunburn erythema, J. Invest. Dermatol. 66: 153–156.
Kantrowitz, F., Robinson, D. R., McGuire, M. B., and Levine, L., 1975, Corticosteroids inhibit prostaglandin production by rheumatoid synovia, Nature (London) 258: 757–739.
Katz, D. H., and Benacerraf, B., 1972, The regulatory influence of activated T cells on B cells responses to antigen, Adv. Immunol. 15: 2–94.
Kayashima, K., Koga, T., and Onoue, K., 1976, Role of T lymphocytes in adjuvant arthritis. I. Evidence for the regulatory function of thymus-derived cells in induction of the disease, J. Immunol. 117: 1878–1882.
Kerbel, R. S., and Eidinger, D., 1971, Variable effects of antilymphocyte serum on humoral antibody formation: Role of thymus dependency of antigen, J. Immunol. 106: 917–926.
Kersey, J. H., Spector, B. D., and Good, R. A., 1973, Immunodeficiency and cancer, Adv. Cancer Res. 18: 211–230.
Kischer, C. W., 1973, In vitro contraction of embryonic skin produced by prostaglandins, Experientia 29: 30–31.
Kocsis, J. J., Hernandovich, J., Silver, M. J., Smith, J. B., and Ingerman, C., 1973, Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin, Prostaglandin 3: 141–144.
Krakauer, K. A., Torrey, S. B., and Zurier, R. B., 1978, Prostaglandin Ei treatment of NZB/W mice. III. Preservation of spleen cell concentrations and mitogen-induçed proliferative responses, Clin. Immunol. Immunopathol. 11: 256–266.
Kreiner, P. W., Gold, C. J., Brock, W. A., and Bitensky, M. W., 1973, MSH sensitive adenyl cyclase in cloud-man melanoma, Yale J. Biol. Med. 46: 583–591.
Kuehl, F. A., 1974, Prostaglandins, cyclic nucleotides and cell function, Prostaglandins 5: 325–340.
Kuehl, F. A., Humes, J. L., Egan, R. W., Ham, E. A., Beveridge, G. C., and Van Arman, C. G., 1977, Role of prostaglandin endoperoxide PGG2 in inflammatory processes, Nature (London) 265: 170–173.
Lewis, G. P., 1971, Role of kinins and prostaglandins as mediators of functional hyperemia, Proc. R. Soc. Med. 64: 6–9.
Lewis, G. P., and Piper, P. J., 1975, Inhibition of release of prostaglandins as an explanation of some of the actions of antiinflammatory corticosteroids, Nature (London) 254: 308–310.
Lewis, G. P., and Piper, P. J., 1977, Two sites of action of steroids on the prostaglandin system, in: Perspectives in Inflammation ( D. Willoughby, ed.), pp. 519–524, MTP Press, Lancaster, England.
Lichtenstein, L. M., and DiBernardo, R., 1971, The immediate allergic response: In vitro action of cyclic AMP active and other drugs on the two stages of histamine release, J. Immunol. 107: 1131–1136.
Loose, L. D., and DiLuzio, N. R., 1973, Effect of prostaglandin Ei on cellular and humoral immune responses, J. Reticuloendothel. Soc. 13: 70–77.
Lupulescu, A. P., 1977, Cytologic and metabolic effects of prostaglandins on rat skin, J. Invest. Dermatol. 68: 138–145.
Mathur, G. P., and Ghandi, V. M., 1972, Prostaglandin in human and albino rat skins, J. Invest. Dermatol. 58: 291–295.
McClatchey, W., and Snyderman, R., 1976, Prostaglandins and inflammation: Enhancement of monocyte chemotactic responsiveness by prostaglandin E2, Prostaglandins 12: 415–421.
Melmon, K. L., Bourne, H. R., Weinstein, Y., Shearer, G. M., Kram, J., and Bauminger, S., 1974, Hemolytic plaque formation by leucocytes in in vitro control by vasoactive hormones, J. Clin. Invest. 53: 13–21.
Moellman, G., McGuire, J., and Lerner, A. B., 1973, Intracellular dynamics and the fine structure of melanocytes with special references to the effects of MSH and cyclic AMP on microtubules and 10 nm filaments, Yale J. Biol. Med. 46: 337–360.
Mohrhauer, H., and Holman, R. T., 1963, Alteration of the fatty acid composition of brain lipids by varying levels of dietary essential fatty acids, J. Neurochem. 10: 523–530.
Morley, J., 1974, Prostaglandins and lymphokines in arthritis, Prostaglandins 8: 315–326.
Mosier, D. E., 1967, A requirement for two cell types for antibody formation in vitro, Science 158: 1575–1577.
Mozes, E., Shearer, G. M., Melmon, K. L., and Bourne, H. R., 1973, In vitro correction of antigen induced immune suppression: Effects of poly(A) poly(U) and prostaglandin El, Cell. Immunol. 9: 226–233.
Murphy, R. C., Hammarstrom, A., and Samuelsson, B., 1979, Leukotriene C: A slow-reacting substance from murine mastocytoma cells, Proc. Natl. Acad. Sci USA 76: 4275–4279.
Newcombe, D. S., and Ishikawa, Y., 1976, The effect of anti-inflammatory agents on human synovial fibroblast prostaglandin synthetase, Prostaglandins 12: 849–869.
Orange, R. P., Austen, W. G., and Austen, K. F., 1971, Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic AMP, J. Exp. Med. 134: 136s - 148s.
Oyanagui, R., 1976, Participation of superoxide anions at the prostaglandin phase of carrageenan foot-oedema, Biochem Pharmacol. 25: 1465–1472.
Peck, M. J., and Williams, T. J., 1978, Prostacyclin (PGI2) potentiates bradykinin-induced plasma erudation in rabbit skin, Br. J. Pharmacol. 62: 464D.
Penneys, N. S., Zibok, V., Gottlieb, N. L., and Katz, S., 1974, Inhibition of prostaglandin synthesis and human epidermal enzymes by aurothiomalate in vitro: Possible actions of gold in pemphigus, J. Invest. Dermatol. 63: 356–361.
Penneys, N. S., Lord, J. T., Ziboh, V. A., and Simon, P., 1977, Inhibitors of prostaglandin biosynthesis and epidermal injury, Prostaglandins 14: 355–362.
Quagliata, F., Lawrence V. J. W., and Phillips- Quagliata, J. M., 1973, Prostaglandin El as a regulator of lymphocyte function. Selective action on lymphocytes and synergy with procarbazine in depression of immune responses, Cell. Immunol. 6: 457–465.
Rasmussen, H., 1970, Cell communication, calcium ion, and cyclic adenosine monophosphate, Science 170: 404–412.
Robinson, D. R., Tashjian, A. H., and Levine, L., 1975, Prostaglandin stimulated bone resorption by rheumatoid synovia. A possible mechanism for bone destruction in rheumatoid arthritis, J. Clin. Invest. 56: 1181–1188.
Rosenthale, M. E., Dervinis, A., Kassarich, J., and Singer, S., 1972, Prostaglandins and antiinflammatory drugs in the dog knee joint, J. Pharm. Pharmocol. 24: 149–50.
Sauk, J. J., White, J. G., and Witkop, C. J., 1975, Influence of prostaglandins Ei, E2 and arachidonate on melanosomes in melanocytes and keratinocytes of anagen hair bullos in vitro, J. Invest. Dermatol. 64: 332–337.
Schied, M. P., Goldstein, G., Mammerling, U., and Boyse, E. A., 1975, Lymphocyte differentiation from precursor cells in vitro, Ann. N.Y. Acad. Sci. 249: 53 1540.
Simon, P., Penneys, N. S., Lord, J. T., Ziboh, V. A., and Mundy, S., 1977, A human model system for the release of endogenous inhibitors of prostaglandin biosynthesis, Prostaglandins 14: 363–369.
Smith, J. B., and Willis, A. L., 1971, Aspirin selectively inhibits prostaglandin production in human platelets, Nature (London) New Biol. 231: 235–237.
Smith, J. W., Steiner, A. L., and Parker, C. W., 1971, Human lymphocyte metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin, J. Clin. Invest. 50: 442–448.
Snyder, D. S., 1975, Cutaneous effects of topical indomethacin, an inhibitor of prostaglandin synthesis in UV-damaged skin, J. Invest. Dermatol. 64: 322–326.
Sobotka, A., Marone, G., and Lichtenstein, L., 1978, Arachidonic acid (AA) metabolism and basophil histamine release (HR), National Institutes of Health Meeting on Asthma and Allergic Diseases Program, November 30th, 1978.
Sfandergaard, J., and Greaves, M. W., 1971. Prostaglandin El: Effect on human cutaneous vasculature and skin histamine, Br. J. Dermatol. 84: 424–428.
Talai, N., 1975, Animal models for systemic lupus erythematosus, Clin. Rheum. Dis. 1: 485–492.
Tashjian, A. J., Voelkel, E. F., McDonough, J., and Levine, L., 1975, Hydrocortisone inhibits prostaglandin production by mouse fibrosarcoma cells, Nature (London) 258: 739–741.
Turner, S. R., Tainer, J. A., and Lynn, W. S., 1975, Biogenesis of chemotactic molecules by the arachidonate lipoxygenase system of platelets, Nature (London) 257: 680–681.
Van Dorp, D. A., 1971, Recent developments in the biosynthesis and the analyses of prostaglandins, Ann. N.Y. Acad. Sci. 180: 181–195.
Vane, J. R., 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin like drugs, Nature (London) New Biol. 231: 232–235.
Velo, G. P., Dunn, C. J., Giroud, J. P., Timsit, J., and Willoughby, D. A., 1973, Distribution of prostaglandins in inflammatory exudate, J. Pathol. 111: 149–157.
Voorhees, J. J., 1977, Pathophysiology of psoriasis, Annu. Rev. Med. 28: 467–473.
Webb, D. R., and Jamieson, A. T., 1976, Control of mitogen-induced transformation: Characterization of a splenic suppressor cell and its mode of action, Cell. Immunol. 24: 45–49.
Webb, D. R., and Nowowiejski, I., 1977, The role of prostaglandins in the control of the primary 19s immune response to sRBC, Cell. Immunol. 33: 1–10.
Whitfield, J. F., MacManus, J. P., Braceland, B. M., and Gillan, D. J., 1972, The influence of calcium on the cyclic AMP-mediated stimulation of DNA synthesis and cell proliferation by prostaglandin E1, J. Cell. Physiol. 79: 353–359.
Wikswo, M. A., 1973, Action of cyclic AMP on pigment donation between mammalian melanocytes and keratinocytes, Yale J. Biol. Med. 46: 592–601.
Williams, T. J., 1977, Oedema and vasodilatation in inflammation: The relevance of prostaglandins, Postgrad. Med. J. 53: 660–662.
Willis, A. L., 1969a, Release of histamine, kinin and prostaglandins during carageenin induced inflammation in the rat, in: Prostaglandins, Peptides and Amines ( P. Mantegozza and E. W. Horton, eds.), pp. 31–38, Academic Press, London.
Willis, A. L., 1969b, Parallel assay of prostaglandin-like activity in rat inflammatory exudate by means of cascade superfusion, J. Pharm. Pharmacol. 21: 126–128.
Willis, A. L., and Cornelson, M., 1973, Repeated injection of prostaglandin E2 in rat paws induces chronic swelling and a marked decrease in pain threshold, Prostaglandins 3: 353–358.
Yamamoto, I., and Webb, D. R., 1975, Antigen stimulated changes in cyclic nucleotide levels in the mouse, Proc. Natl. Acad. Sci. USA 72: 2320–2324.
Ziboh, V. A., 1973, Biosynthesis of prostaglandin E2 in human skin: Subcellular localization and inhibition by unsaturated fatty acids and antiinflammatory drugs, J. Lipid Res. 14: 377–384.
Ziboh, V. Q., Price B., and Fulton, J., 1975, Effects of retinoic acid on prostaglandin biosynthesis in guinea pig skin, J. Invest. Dermatol. 65: 370–374.
Zimecki, M., and Webb, D. R., 1976, The regulation of the immune response to T independent antigens by prostaglandins and B-cells, J. Immunol. 117: 2158–2162.
Zurier, R. B., 1974, Prostaglandins, inflammation, and asthma, Arch. Intern. Med. 133: 101–110.
Zurier, R. B., and Ballas, M., 1973, Prostaglandin E1 suppression of adjuvant arthritis: Histopathology, Arthritis Rheum. 16: 251–258.
Zurier, R. B., and Quagliata, F., 1971, Effect of prostaglandin E2 on adjuvant arthritis, Nature (London) 234: 304–305.
Zurier, R. B., and Sayadoff, D. M., 1975, Release of prostaglandin from human polymorphonuclear leucocytes, Inflammation 1: 93–102.
Zurier, R. B., Hoffstein, S., and Weissmann, G., 1973, Suppression of acute and chronic inflammation in adrenalectomized rats by pharmacologic amounts of prostaglandins, Arthritis Rheum. 16: 606–615.
Zurier, R. B., Weissman, G., Hoffstein, S., Kammerman, S., and Tai, H. H., 1974, Mechanisms of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function, J. Clin. Invest. 53: 297–309.
Zurier, R. B., Cosgrove, J., and Hinz, C. G., 1975, Enhancement by CAMP and PGE, of cytotoxicity mediated by human monocytes, Fed. Proc. 34: 1029.
Zurier, R. B., Sayadoff, D. M., Torrey, S. B., and Roth-Field, N. F., 1977a, Prostaglandin E1 treatment of NZB/ W mice. I. Prolonged survival of female mice, Arthritis Rheum. 20: 723–728.
Zurier, R. B., Damjanov, I., Sayadoff, D. M., and Roth-Field, N. F., 1977b, Prostaglandin E1 treatment of NZB/ W mice. II. Prevention of glomerulonephritis, Arthritis Rheum. 20: 1449–1456.
Zurier, R. B., Dore-Duffy, P., and Viola, M. V., 1977c, Adherence of human peripheral blood lymphocytes to measles infected cells. Enhancement by prostaglandin E1, N. Engl. J. Med. 296: 1443–1446.
Zurier, R. B., Doty, J., and Goldenberg, A., 1977d, Cyclic AMP response to prostaglandin E1 in mononuclear cells from peripheral blood and synovial fluid of patients with rheumatoid arthritis, Prostaglandins 13: 25–31.
Zurier, R. B., Damjanov, I., Miller, P. L., and Biewer, B. F., 1978, Prostaglandin E1 treatment prevents progression of nephritis in murine lupus erythematosus, J. Clin. Lab. Immunol. 1: 95–98.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1981 Plenum Publishing Corporation
About this chapter
Cite this chapter
Zurier, R.B., Ramwell, P.W. (1981). Prostaglandins and Other Arachidonate Metabolites. In: Safai, B., Good, R.A. (eds) Immunodermatology. Comprehensive Immunology, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-7228-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-4615-7228-2_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-7230-5
Online ISBN: 978-1-4615-7228-2
eBook Packages: Springer Book Archive